Month: February 2013

Kadcyla Approved for Late-Stage Breast Cancer

The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer. HER2 is a protein involved in normal cell growth. It...

Read More

America’s Best Hospitals in 2013

According to a new report released this week from Healthgrades, of the nation’s 50 top hospitals in terms of patient outcomes, 21 (42%) are in 7 Midwestern states. And of the nation’s top 20 cities with the lowest...

Read More

Fall Risks High for Those With HIV

Middle-aged patients infected with HIV appear to have a high risk for falls. A study found that multiple comorbidities, medications, and functional impairment were predictive of falls. Of 359 subjects, 250 persons (70%) reported...

Read More

For latest news and updates
Email-id is invalid